Revitalist Announces Closing of Cdn$3 million Private Placement Offering with Institutional Investors

Rhea-AI Summary

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM, OTC: RVLWF) has successfully closed a private placement, raising approximately Cdn$3,000,000.08. The Company issued 5,357,143 units at Cdn$0.56 per unit, each including a common share and a warrant. The warrants are exercisable at Cdn$0.69 until November 17, 2026. Proceeds will support working capital, clinic expansion, and corporate infrastructure. The placement was facilitated by H.C. Wainwright & Co., with a commission of Cdn$210,000.01 and additional warrants issued.

Positive

• Raised approximately Cdn$3,000,000 through a private placement.
• Facilitated by a reputable placement agent, H.C. Wainwright & Co.
• Warrants provide additional financing potential until 2026.
• Proceeds aimed at expanding clinic network and corporate infrastructure.

Negative

• None.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to announce that it has closed its previously announced private placement to institutional investors of units (“Units”) for aggregate gross proceeds to the Company of approximately Cdn$3,000,000.08 (the “Private Placement”). Pursuant to the Private Placement, the Company issued 5,357,143 Units at a purchase price of Cdn$0.56 per Unit. Each Unit consists of one common share of the Company (a “Common Share”) and one common share purchase warrant (each a “Warrant”), each Warrant entitling the holder thereof to purchase one Common Share at an exercise price of Cdn$0.69 at any time on or prior to November 17, 2026.

H.C. Wainwright & Co. acted as the exclusive placement agent for the private placement in the United States. H.C. Wainwright & Co. received: (i) a cash commission of Cdn$210,000.01, and (ii) 375,000 warrants (the “Agent Warrants”), each Agent Warrant entitling the holder thereof to purchase one Common Share at an exercise price of Cdn$0.56 per Common Share at any time on or before November 17, 2026.

The net proceeds of the Private Placement are expected to be used by the Company for working capital and general corporate purposes, including, without limitation, expansion of the number of clinics throughout North America, increase of corporate infrastructure to sustain the foregoing, acquisitions of assets used in the Company’s business and strategic transactions and/or acquisitions. Details as to the intended specific allocation of the proceeds are disclosed in the Prospectus Supplement referred to below and further business development announcements will be made by Revitalist in due course as they arise.

The Common Shares and Warrants issued under the Private Placement were qualified by way of a prospectus supplement dated November 16, 2021 under the Company’s base shelf prospectus dated October 29, 2021 (collectively, the “Prospectus Supplement”) which was filed in each of the provinces of Canada, except Québec, copies of which are available under the Company’s profile at www.sedar.com. The Common Shares and Warrants were offered and sold in the United States on a private placement basis pursuant to exemptions from the registration requirements of the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) and all applicable state securities laws, and in certain other jurisdictions in accordance with applicable securities laws. No securities were offered or sold to Canadian purchasers.

This news release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in Canada in connection with the Private Placement.

This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This news release shall not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the U.S. Securities Act and such securities may not be offered or sold within the United States absent registration under U.S. federal and state securities laws or an applicable exemption from such U.S. registration requirements.

ABOUT REVITALIST LIFESTYLE AND WELLNESS

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a publicly traded company, headquartered in Knoxville, Tennessee, with five clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided thousands of infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness. For more information, please visit www.revitalist.com or follow us at:

Twitter: @RevitalistCorp
Facebook: @RevitalistLifestyleandWellnessLtd
Instagram: @RevitalistCorp
LinkedIn: @RevitalistLifestyleAndWellnessLtd

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws relating to the Company’s business plans and the outlook of the Company’s industry. Forward-looking statements contained in this news release include statements regarding the use of proceeds from the Private Placement. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Such information can generally be identified by the use of forwarding looking wording such as “may”, “expect”, “estimate”, “anticipate”, “intend”, “believe” and “continue” or the negative thereof or similar variations. The reader is cautioned that assumptions used in the preparation of any forward- looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including but not limited to, market and other conditions, volatility in the trading price of the Common Shares; business, economic and capital market conditions; the ability to manage operating expenses, which may adversely affect the Company’s financial condition; the ability to remain competitive as other better financed competitors develop and release competitive products; regulatory uncertainties; the ability to manage working capital; and the dependence on key personnel. Revitalist may not actually achieve its plans, projections, or expectations. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the demand for its products and services, the ability to successfully complete the acquisition of additional clinics, that there will be no regulation or law that will prevent the Company from operating its business, anticipated costs, the ability to secure sufficient capital to complete its business plans. Given these risks, uncertainties and assumptions, readers should not place undue reliance on these forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include, failure to obtain regulatory approval, the continued availability of capital and financing, the impact of Covid-19 or other viruses and diseases on the Company’s ability to operate, secure equipment, and hire personnel, competition, potential litigation, increase in operating and labor costs, loss of key employees and consultants, and general economic, market or business conditions. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made by third parties in respect of the matters discussed above.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211118005573/en/

On Behalf of the Board

Kathryn Walker

Chief Executive Officer

Revitalist Lifestyle and Wellness Ltd.

Email: IR@revitalist.com

Tel: (865) 585-8414

Source: Revitalist Lifestyle and Wellness Ltd.

FAQ

What was the total amount raised in the Revitalist private placement?

Revitalist raised approximately Cdn$3,000,000 through the private placement.

What will the proceeds from the private placement be used for?

The proceeds will be used for working capital, clinic expansion, and corporate infrastructure.

What is the exercise price of the warrants issued in the private placement?

The warrants issued have an exercise price of Cdn$0.69.

Who acted as the placement agent for Revitalist's private placement?

H.C. Wainwright & Co. was the exclusive placement agent.

When do the warrants issued by Revitalist expire?

The warrants expire on November 17, 2026.